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The structures of several powerful inhibitors of hydrolytic enzymes
resemble that of the altered substrate in the transition state,
except that a hydrogen atom replaces one substituent (typically
the leaving group). To test the hypothesis that a water molecule
might be present in the gap resulting from this replacement, we
examined a transition-state analogue complex formed by Esche-
richia coli cytidine deaminase by Fourier transform ion cyclotron
resonance MS in electrospray mode. Upon nebularization from
aqueous solution under conditions (pH 5.6) where the enzyme is
active, cytidine deaminase remains dimeric in the vapor phase. In
the presence of inhibitor, the enzyme’s exact mass can be used to
infer the presence at each active site of zinc, 5-fluoro-3,4-dihy-
drouridine, and a single water molecule.
In the design of powerful enzyme inhibitors, the altered sub-strate in the transition state can be considered to represent an
ideal ligand, for which the binding affinity of an enzyme has been
optimized through natural selection. Because the properties of
this short-lived species (t1/2  1013 s at 25°C) will never be
matched exactly by those of any molecule with stable geometry,
it is not surprising that even the most powerful inhibitors that
have been designed on this basis are bound with an affinity (as
judged by their Ki values as competitive inhibitors) that falls short
of the ideal affinity that is estimated by comparing the second-
order rate constant for the enzyme reaction (kcatKm) with the
first-order rate constant (knon) for the reaction in water in the
absence of a catalyst (1, 2).
Some enzyme inhibitors do, nonetheless, capture much of the
negative free energy of binding that would be expected of an
ideal transition-state analogue, and the shortcomings of these
unusually powerful inhibitors are of special interest. Several
nucleoside deaminases and proteases, for example, are strongly
inhibited by molecules in which a hydrogen atom replaces the
leaving ammonia or amino group that would ordinarily be
present in tetrahedral intermediates that approach the transition
state in structure (Fig. 1). Such a truncated inhibitor would be
expected to occupy much of the space that is normally occupied
by the altered substrate in the transition state, except that a gap
would presumably remain where the attacking or leaving group
of the substrate had been replaced by a hydrogen atom. The
appearance of that gap might result in the trapping of one or
more water molecules, or the active site might collapse in such
a way as to fill the gap. Either of these developments would be
expected to be energetically unfavorable compared with the
presumably optimal binding of the altered substrate in the
transition state (3).
One enzyme for which this question has arisen is Escherichia
coli cytidine deaminase (CDA), which consists of two symmet-
rical subunits (2  31,539 Da) with one active site per subunit
(4). The active sites, which lie at the dimer interface, operate
independently (5), and each is equipped with a zinc atom that is
involved in the covalent addition of water to cytidine, followed
by elimination of ammonia (Scheme 1) (6). The enzymatic and
nonenzymatic reactions are both pH-independent, and each
appears to proceed by a two-step mechanism that involves
stepwise addition of zinc-coordinated hydroxide to form a
tetrahedral intermediate, followed by rate-limiting elimination
of NH3 (6). CDA is strongly inhibited by stable analogues
resembling a transition state that is sp3-hybridized at C-4:
3,4-dihydrouridine (DHU) and its 5-f luorinated analogue,
5-f luoro-DHU (FDHU), which is formed by enzyme-catalyzed
3,4-addition of water to the corresponding 5-fluoropyrimidin-
2-one ribonucleoside (FZeb) (Fig. 1). These analogues exhibit
comparable affinities for CDA, surpassing the substrate or
product in their negative free energies of binding by 10–11
kcalmol. However, their affinities fall short of the affinity of the
altered substrate in the transition state [estimated by comparing
the rates of the enzymatic (kcatKm) and nonenzymatic (knon)
reactions] by 5–6 kcalmol. In a recent investigation of the basis
of this shortfall, the thermodynamic changes that accompany the
binding of DHU by CDA were compared with those that
accompany the binding of the distorted form of the substrate that
is present in the transition state (7). The enthalpies of binding of
DHU and the altered substrate in the transition state were found
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Fig. 1. Chemical structure and exact mass of FZeb, also named 5-fluoro-
zebularine (A), and its hydrated version, the transition-state analogue FDHU
(B), which is obtained by the CDA-catalyzed 3,4-addition of water to FZeb.







to differ by 1 kcalmol, as would perhaps be expected whether
similar polar forces of attraction were at work. However, the
entropy of binding of this transition-state analogue (in which a
hydrogen atom replaces the leaving amino group of cytidine) was
found to be markedly less favorable (Scheme 2), and the
magnitude of that difference was large enough to account for the
shortcomings of the inhibitor as a ideal transition-state analogue.
To explain the less-than-ideal entropy of DHU, it was sug-
gested that binding of this inhibitor might be accompanied by the
unfavorable trapping of an extra water molecule within the active
site, in the space vacated by the nitrogen atom of the missing
4-NH2 group (Scheme 2 Lower). During the enzyme-catalyzed
reaction, the substrate’s ribose substituent remains fixed in
position within the active site, whereas the 4-carbon of the
pyrimidine ring describes an arc with respect to the fulcrum of
C-1, away from the leaving group ammonia and toward the
zinc-bound hydroxide ion (8). In the crystal structure of the
enzyme–uridine complex, a water molecule was found to be
present at the site considered to be occupied by the leaving group
ammonia, in the normal reaction (8). The crystal structure of the
enzyme’s complex with FDHU (4) does not reveal the presence
of such a water molecule, but does indicate the presence of a gap
that may be large enough to accommodate a water molecule, at
a position that would be sealed off from bulk solvent when the
analogue was bound (7).
We considered it possible, at least in principle, that the
presence of a water molecule in the inhibitory complex might be
detected by accurate MS analysis of CDA in the presence and
absence of a transition-state analogue inhibitor. In electrospray
ionization MS analysis, proteins are ordinarily nebularized from
acid solution to enhance the number of positive charges on the
protein and reduce the value of mz. That procedure tends to
remove associated water molecules, revealing peaks that corre-
spond to the mass of a ‘‘naked,’’ denatured form of the protein
(9). Here, we describe the initial results of using Fourier
Scheme 1. Cycle of events during the enzymatic deamination of cytidine (4).
Note that substrate water is present in ‘‘split’’ form on the free enzyme in
solution.
Scheme 2. Thermodynamic changes that accompany ligand binding by CDA (7).
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transform ion cyclotron resonance (FTICR)-MS to analyze
CDA, in the presence and absence of the inhibitor FZeb, under
nondenaturating conditions (pH 5.6) where the protein retains
activity in solution (5).
Materials and Methods
Recombinant CDA was expressed in E. coli and purified to
homogeneity as described earlier (10, 11). The enzyme was
dialyzed against ammonium acetate (5  103 M, pH 5.6) to
produce a concentration of 5  106 M in monomer. For MS
analysis, CDA was diluted with water to a final concentration
of 1  106 M in monomer. Spectra of the acid-inactivated
monomeric enzyme were obtained by analyzing CDA in the
presence of 50% methanol and 2% acetic acid. Samples of the
native enzyme in the presence and absence of inhibitor were
acidified just before nebularization by addition of acetic acid,
to produce a final concentration of 0.5%, without addition of
other organic solvents. MS analyses were performed by using
a hybrid Qq-FTICR mass spectrometer (Apex-Qq), equipped
with either a 7- or 9.4-T actively shielded magnet (Bruker
Daltonics), and an Apollo electrospray source. The capillary
entrance voltage used to induce the electrospray ionization
was between 3,900 and 4,200 V. Desolvation was carried out by
using a countercurrent drying gas with a source temperature
maintained at 150°C. The skimmer voltage applied (i.e., the
potential difference between the skimmer and the capillary
exit) varied between 164 and 181 V. Before transfer and
detection, ion packets were accumulated in the collision cell of
the system for a duration of 1–3 s. Samples were introduced by
direct infusion with a 100-l syringe (Harvard Apparatus)
operated at a f low rate of 1 lmin.
Results
For accurate determination of the molecular mass of E. coli
CDA, the protein was first analyzed under denaturing condi-
tions, in a 50% methanol2% acetic acid ratio, to disrupt the
natural dimeric structure of the native enzyme in solution. By
using a 9.4-T Bruker Qq-FTICR-MS, the mass spectrum showed
isotopic resolution (Fig. 2), indicating 31,539 Da as the most
abundant isotopic mass. That value is exactly equivalent to the
mass expected from the elemental composition of the mono-
meric enzyme, with no zinc atoms and no associated water
molecules. Subsequent analyses were performed by using a 7-T
FTICR, because, for these experiments, the mass accuracy is
easily sufficient for determination of the number of water
molecules that are present in a protein.
When we conducted this experiment by using enzyme
dialyzed against ammonium acetate (0.005 M, pH 5.6), we
observed one major ion series corresponding to the mass of the
dimeric protein, containing two zinc atoms per dimer (Fig.
3A). We observed that methanol, even in small amounts,
prevented dimer formation, but that acetic acid (0.5%), added
just before nebularization, was necessary to obtain ion signals
related to dimeric CDA, which contains one zinc atom at each
of its active sites.
When we conducted the same experiment in the presence of
two equivalents of the inhibitor FZeb, the mass spectrum showed
three species, 264 Da apart, after deconvolution (Fig. 3B).
These mass increments of 264 Da are equivalent to the mass of
the transition-state analogue FDHU (the covalently hydrated
form of the inhibitor FZeb, expected to be formed at the active
site) (Fig. 1). The relative magnitudes of these three ion signals
were found to depend on the skimmer voltage applied (the
potential difference between the capillary exit and the skimmer,
data not shown), as expected, if the inhibitor were noncovalently
bound by the enzyme. However, in experiments involving nebu-
larization of the CDA–FZeb complex, the absolute masses from
the ion signals corresponded to dimeric CDA, including two zinc
atoms and two water molecules (63,226.6 Da) (Fig. 3B), and
exceeded the molecular mass determined for dimeric CDA
(prepared in the absence of FZeb) by 35 Da (Fig. 3A). That
difference is equivalent within experimental error to the mass of
two water molecules (36 Da), and can be explained by the
structure of the free enzyme in Scheme 1, showing that one water
molecule is bound in ‘‘split’’ form, with its hydroxide portion
bound by Zn and its proton bound by Glu-104. The additional
mass of 264 Da per active site is consistent with the view that, in
the inhibitory complex, each active site contains two water
molecules, one of which is covalently bound as part of FDHU,
and one of which is noncovalently caught in the gap between the
transition-state analogue and the surface of the active site, as
shown in Scheme 2.
MS cannot exclude the alternative possibility that the proton-
ated reaction product NH4, with an expected mass increment
of 18 Da, might be present in place of one or both of the two
postulated water molecules in the enzyme–FZeb complex. How-
ever, earlier work has shown that E. coli CDA exhibits an
extremely weak affinity for ammoniaammonium ion as a com-
petitive inhibitor (Ki  1 M) (12), indicating that even high
concentrations of ammoniaammonium do not displace water
from the active site. In the present experiments, the enzyme was
nebularized from a solution containing ammonium acetate at a
final concentration of 103 M, at least 3 orders of magnitude
lower than the apparent Kd value.
Discussion
If an extra, noncovalently bound, water molecule were present
in the transition-state analogue complexes that CDA forms
with FDHU, and if that water molecule were sealed off from
exposure to (and from equilibration with) the nearly perfect
vacuum (1010 torr; 1 torr  133 Pa) that is present within
the chamber of the ion cyclotron, then the molecular mass of
the enzyme–inhibitor complex might reveal the presence of
that second water molecule. If the active site simply collapsed
to fill the gap, then no excess water would be expected to be
present in the inhibitor complex. In the present experiments,
we sought to distinguish between these alternatives by collect-
ing the mass spectrum of E. coli CDA in the presence and
absence of a transition-state analogue inhibitor.
Fig. 2. FTICR-MS analysis of CDA under denaturing conditions by using a
Bruker Apex Qq-FTICR equipped with a 9.4 T magnet. The deconvoluted
spectrum obtained (solid line) is superimposed on the theoretical isotopic
distribution of CDA (dashed line) derived from its elemental composition. The
most abundant mass agrees with the theoretical mass within 2 ppm (0.13 Da).
theo., theoretical; deter., experimentally determined; MW, molecular mass.







In the presence of FZeb, CDA remains dimeric in the vapor
phase, yielding an exact mass that can be used to infer the
presence of zinc, the transition-state analogue FDHU (co-
valently hydrated FZeb), and a single additional water molecule
at each active site. The feasibility of this experiment reveals (and
depends on) the surprising stability of the enzyme–inhibitor
complex in the vapor phase at high vacuum. We found that the
signal from this complex persisted for several seconds even at
the very high vacuum (1010 torr) that is present within the
chamber of the ion cyclotron. It appears that both the water
molecule in FDHU, incorporated by the enzyme-catalyzed
3,4-addition of water to FZeb (3), and an additional water
molecule that is trapped in the inhibitory complex are slow to
equilibrate with the nearly perfect vacuum that surrounds the
protein in the vapor phase.
Why does the dimeric enzyme nebularized in the absence of
inhibitor contain no water, whereas enzyme nebularized from
saturating inhibitor appear to contain a water molecule within
each active site?
At equilibrium in the high vacuum present within the chamber
of the spectrometer, one would expect that all water molecules,
including the water molecule that is covalently bound as part of
FDHU, would be lost. When the enzyme is nebularized under
nondenaturing conditions in the absence of FZeb, its active site
is unprotected from the nearly perfect vacuum within the
chamber. We speculate that water is quickly lost from the active
site, although the protein retains zinc and remains dimeric.
Consistent with that possibility, the effect of solvent deuterium
on kcatKm (6) suggests that the ‘‘splitting’’ of water (Scheme 1)
does not occur before the binding of substrate cytidine. Accord-
ingly, it seems understandable that water appears to be lost in the
absence of FZeb.
The apparent kinetic stability of the enzyme–inhibitor com-
plex in the vapor phase, together with its water molecules, seems
more surprising. That stability implies that in the absence of
solvent water, the structure of the complex is maintained at least
for several seconds. The apparent dissociation constant of the
enzyme’s complex with FZeb (107 M) in solution is such that
this inhibitor should be released easily at low inhibitor concen-
trations. Moreover, dissociation would be expected to be addi-
tionally favored at high vacuum because one water molecule is
produced stoichiometrically when FDHU undergoes spontane-
ous dehydration (Keq  3,000) to form FZeb (5). In the presence
of FZeb, we speculate that a water molecule is trapped at each
active site, protected against dissociation while the inhibitory
complex remains intact. The crystal structure shows that FDHU
is surrounded by the active site to such an extent that 0.5% of
the inhibitor is accessible to bulk solvent (4). In solution, the
kinetic barrier to inhibitor release is substantial (koff  0.01 s1;
G.K.S. and M.J.S., unpublished work). If the same were true in
the vapor phase, then the complex would be expected to remain
largely undissociated during the few seconds that elapse between
nebularization and detection in the vapor phase. Thus, it seems
reasonable to suppose that the mass spectrum represents a
sampling of the enzyme–inhibitor complex in the course of
irreversible dissociation in the vapor phase.
Fig. 3. FTICR-MS analysis of CDA under nondenaturing conditions by using a Bruker 7-T Apex Qq-FTICR in the absence (A) and the presence (B) of FZeb. After
deconvolution of the multiply charged ion signals, a mass difference of 35 Da was observed for the complex of dimeric CDA plus two zinc ions after incubation
with FZeb, which corresponds to 0.95 water molecules per monomer of CDA. In addition, the presence of a second water molecule is revealed by the detection
of species at 63,489 and 63,756 Da, corresponding to complexes consisting of dimeric CDA, two zinc ions, two water molecules, and either one or two molecules
of FDHU, respectively.
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Finally, the fact that the enzyme retains its affinity for FDHU
in its intact, hydrated form in the vapor phase implies that the
active site retains its native structure for a substantial period in
the absence of solvent water. The persistence of a dimeric
structure and the retention of zinc, even in the absence of FZeb,
suggests that, even in the absence of the hydrophobic effect,
other noncovalent forces of attraction remain in effect long
enough to preserve the native structure for many seconds.
Conclusions
In this work, we tested the possibility that the presence of a water
molecule might be detected by accurate MS analysis of enzymes
in the presence and absence of a transition-state analogue
inhibitor. In the presence of FZeb, CDA remains dimeric in the
vapor phase, yielding an exact mass that can be used to infer the
presence at each active site of zinc, FDHU, and a single water
molecule, which remain in place for several seconds even at the
very high vacuum (1010 torr) that is present within the
chamber of the ion cyclotron. To our knowledge, this appears to
be the first demonstration that MS can be used to estimate the
number of water molecules in a protein, whose active site
remains arguably native in the vapor phase because it continues
to bind the transition-state analogue FDHU. The apparent
persistence of the structure of dimeric CDA in the vapor phase
indicates that the presence of solvent water is not necessary for
the continued existence of enzyme structure, at least for short
time intervals, in either the presence or absence of inhibitor.
These findings support the view that water is retained in the
inhibitory complex, as postulated earlier on the basis of entropic
evidence obtained at equilibrium. A more perfect inhibitor
would presumably fill that space.
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